A HIGHLY SENSITIVE AND RAPID RADIOIMMUNOASSAY FOR THE DETERMINATION OF ARGININE(8)-VASOPRESSIN

被引:0
作者
GERBES, AL
WITTHAUT, R
SAMSON, WK
SCHNIZER, W
VOLLMAR, AM
机构
[1] PRIVATKLIN RAPHAEL, BAD GRIESBACH, GERMANY
[2] UNIV MUNICH, INST PHARMAKOL TOXIKOL & PHARM, W-8000 MUNICH 2, GERMANY
[3] UNIV MISSOURI, DEPT ANAT, COLUMBIA, MO 65201 USA
来源
EUROPEAN JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY | 1992年 / 30卷 / 04期
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A highly sensitive radioimmunoassay for arginine8-vasopressin (argipressin; INN) measurement was developed using Amberlite XAD 2 resin columns to extract arginine8-vasopressin from acidified human plasma. Arginine8-vasopressin was determined by a rapid radioimmunoassay method (2 x 20 h) using a specific antibody and I-125-labelled antigen. The bound fraction was separated by adsorption of the free fraction onto bovine serum albumin-coated charcoal; this resulted in low unspecific binding of less than 2%. Recovery experiments in the physiological range resulted in a mean (+/- SEM) recovery of 88 +/- 3%. The radioimmunoassay consistently yielded a detection limit of 0.3 ng/l (ED90) and a mean 50% binding intercept (ED50) of 3.5 ng/l. Arginine8-vasopressin immunoreactivity was characterized by reverse-phase high performance liquid chromatography, which confirmed the specificity of the assay. Serial plasma dilution curves paralleled the standard curve. The intra- and inter-assay variations were 9.4% and 15%, respectively. Arginine8-vasopressin concentrations in healthy subjects were determined in normal hydration status (2.2 +/- 0.3 ng/l; n = 11), as well as during suppression by water immersion (1.5 +/- 0.2 ng/l; n = 11) or by water loading (1.6 +/- 0.2 ng/l; n = 8). Thus, this assay allows for a sensitive, accurate and rapid quantification of plasma arginine8-vasopressin concentrations.
引用
收藏
页码:229 / 233
页数:5
相关论文
共 33 条
[1]   SYNDROME OF INAPPROPRIATE SECRETION OF ANTIDIURETIC HORMONE [J].
BARTTER, FC ;
SCHWARTZ, WB .
AMERICAN JOURNAL OF MEDICINE, 1967, 42 (05) :790-+
[2]   MODULATION OF PLASMA AND PLATELET VASOPRESSIN BY CARDIAC-FUNCTION IN PATIENTS WITH HEART-FAILURE [J].
BICHET, DG ;
KORTAS, C ;
METTAUER, B ;
MANZINI, C ;
MARCAURELE, J ;
ROULEAU, JL ;
SCHRIER, RW .
KIDNEY INTERNATIONAL, 1986, 29 (06) :1188-1196
[3]   EFFECTS ON INTRAVASCULAR PRESSURES OF VASOPRESSIN AND ANGIOTENSIN-II IN DOGS [J].
BIE, P ;
WARBERG, J .
AMERICAN JOURNAL OF PHYSIOLOGY, 1983, 245 (06) :R906-R914
[4]  
BODOLA F, 1988, CLIN CHEM, V34, P970
[5]  
CAMPS J, 1983, CLIN CHEM, V29, P882
[6]   FLUID CONSERVATION IN ATHLETES - RESPONSES TO WATER-INTAKE, SUPINE POSTURE, AND IMMERSION [J].
CLAYBAUGH, JR ;
PENDERGAST, DR ;
DAVIS, JE ;
AKIBA, C ;
PAZIK, M ;
HONG, SK .
JOURNAL OF APPLIED PHYSIOLOGY, 1986, 61 (01) :7-15
[7]   OSMOREGULATION DURING PREGNANCY IN THE RAT - EVIDENCE FOR RESETTING OF THE THRESHOLD FOR VASOPRESSIN SECRETION DURING GESTATION [J].
DURR, JA ;
STAMOUTSOS, B ;
LINDHEIMER, MD .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (02) :337-346
[8]  
EDWARDS CRW, 1970, J ENDOCRINOL, V48, pR11
[9]   ISOOSMOTIC CENTRAL BLOOD-VOLUME EXPANSION SUPPRESSES PLASMA ARGININE VASOPRESSIN IN NORMAL MAN [J].
EPSTEIN, M ;
PRESTON, S ;
WEITZMAN, RE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 52 (02) :256-262
[10]  
FATER DC, 1982, AM J PHYSIOL, V242, P1056